An improving economy coupled with a severe drought that caused increased feed costs for large birds generated a 4.8 percent surge in the 2012 PNC Christmas Price Index®, the whimsical economic analysis by PNC Wealth Management based on the gifts in the holiday classic, “The Twelve Days of Christmas.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/42897-pnc-christmas-price-index
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg) for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C) in adults . This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use (CHMP) in September.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58658-almirall
Bangkok’s Chao Praya river is seeing thousands of local and foreign visitors gathering along it again, all enjoying the usual Loy Krathong’s festive atmosphere which was absent last year due to the severe flood. And among the highlighted spots on the river, Asiatique the Riverfront Entertainment Complex seems to be hosting the grandest happenings with several shows and firework, making the area the most crowded place in the city.
Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
Every 25 seconds, or 1.35 million times a year, a young athlete suffers a sports injury severe enough to go to the emergency room, according to a new research report released today by Safe Kids Worldwide.
The report, “Game Changers,” made possible with support from Johnson & Johnson, takes an in-depth look at data from the U.S. Consumer Product Safety Commission’s National Electronic Injury Surveillance System (NEISS) to explore what type of injuries are sidelining young athletes.
The report also revealed that knee injuries account for one in ten sports-related injuries. Knee injuries, specifically tears to the anterior cruciate ligament (ACL), are disproportionately affecting young female athletes, who are up to eight times more likely to have an ACL injury than male athletes.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62822-safe-kids-worldwide-over-1mil-children-sports-related-emergency-visits
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Merck for Mothers has launched programs aimed at decreasing the number of women across the United States who die from or suffer severe complications related to pregnancy and childbirth.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62776-merck-for-mothers-working-to-reduce-maternal-mortality-rate
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
Anyone who's ever survived a severe weather storm or natural disaster knows that the damage to home and property can be overwhelming, emotionally and financially. Although it is impossible to know exactly when a disaster will strike, State Farm® wants you to be prepared and quickly recover from the unexpected. Your ability to weather the storm may depend on the measures you take today. As the largest property insurer in the nation, State Farm has been helping families manage the risks of everyday life since 1922.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65822-state-farm-severe-weather-disaster-preparedness/
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
Did you use the plywood from your hurricane shutters to build a tree house or use your garage door brace to hold up the bird feeder? If so there’s a good chance your home may not be hurricane ready.
Being properly prepared is paramount during hurricane season. To learn more about how to protect yourself and your property, visit State Farm Learning Center. It can make a big difference to your safety, security and survival. Is your property hurricane ready?
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65822-state-farm-severe-weather-disaster-preparedness/
A recent survey conducted by DSM Nutritional Products found that 83 percent of adults in the U.S. believe worsening eye health is inevitable with age. What many people don’t realize is that there’s a connection between healthy eyes and proper nutrition, and it goes beyond eating carrots.
According to Dr. Kimberly Reed, optometrist and Ocular Nutrition Society board member, “Incorporating certain nutrients into the diet can support a lifetime of healthy vision and help protect against serious conditions, including cataracts and age-related macular degeneration (AMD). The latter affects more than 2 million Americans and can lead to severe visual impairment.”
To view Multmedia News Release, go to: http://www.multivu.com/players/English/7129751-dsm-nutritional-products-eye-health-survey/
